The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients
about
Science review: The use of proton pump inhibitors for gastric acid suppression in critical illnessOutcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study.Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxisStress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic reviewICU director data: using data to assess value, inform local change, and relate to the external world.Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysisThe comparison of extemporaneous preparations of omeprazole, pantoprazole oral suspension and intravenous pantoprazole on the gastric pH of critically ill-patients.Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart reviewEfficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.Intensive care unit capacity strain and adherence to prophylaxis guidelines.Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors.Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trialProtective effect of 3,4-methylenedioxyphenol (sesamol) on stress-related mucosal disease in rats.Deep vein thrombosis and stress ulcer prophylaxis in the intensive care unit.Gastrointestinal prophylaxis in neurocritical care.Stress prophylaxis in intensive care unit patients and the role of enteral nutrition.Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.Stress ulceration: prevalence, pathology and association with adverse outcomes.Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.Stress-related mucosal disease in the critically ill patient.Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan.Stress ulcer prophylaxis in critical illness: a Canadian survey.Occult upper gastrointestinal mucosal abnormalities in critically ill patients.Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial.Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients.Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis.Incidence and risk factors for gastrointestinal bleeding among patients admitted to medical intensive care units.Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit.Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.Prognostic Significance of Elevated Cardiac Troponin in Acute Gastrointestinal BleedingWho cares about preventing acute respiratory distress syndrome?A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.Predicting Prolonged Stay in the ICU Attributable to Bleeding in Patients Offered Plasma Transfusion.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionThe distressing overuse of gastric acid inhibitors.Pharmacists and fastidiousness improve compliance with guidelines for stress ulcer prophylaxis.Stress-related mucosal bleeding in critically ill oncology patients.
P2860
Q24802292-034D5F79-FD26-4813-88E4-88E63CD397E5Q24811541-6DE4BF96-C749-4F24-99E9-D8D0A8077C46Q26768234-618E3BE9-86CE-4FA3-8BFC-C30E4A4FB5F0Q28287257-5702C3C3-BEC7-40A8-93F4-8F52CF628565Q30924470-CB43C11A-D693-46B9-A643-C35BE806CEBDQ33396864-ED59CC12-22AA-4865-9783-CED677012652Q33831121-319271E3-8E5B-4AAE-90EB-129AA06CB89CQ33919309-E7E4EB9B-19D2-4FE6-8715-D141FF2B02EAQ34975573-D4B628B8-E5E6-47F4-A82E-0206D4DD5E35Q35544609-A432F6AE-85A2-49C1-9281-DE5787CF90E7Q35571775-AF701D19-3E50-4A85-8AB9-5E35992A63CAQ36007773-EA082E08-7FA3-4D6B-9EB6-B82710A384B7Q36236868-32F69830-81A6-4D33-AD1E-63381F4B9F4FQ36603193-5EF6F9DA-BA79-4705-B46F-AFEDA01000A7Q36815246-F41CBA2C-1E1B-4A9E-9ED7-0D7C5BC1A80EQ37091006-99862245-33E1-4C58-964B-C17C926C700CQ37867319-C5508067-6A56-44CE-A5D5-A027E17D2F27Q37900222-6B0A8020-7D18-470B-A888-34940E147F00Q37993057-8D592000-0E4A-4818-B6A7-959A8318DEA9Q38025609-8B8BC83C-532C-485F-A859-BD43795996AAQ38230155-78C5E8A6-7A4C-46A0-90D0-FC3191178AC9Q38271282-500CAE94-EDBB-42F4-819C-3B443B340034Q38308249-1C71BBEF-D4F3-4719-AC58-4C8BFAD0CCAAQ38728261-F5BF42B5-4448-4DC1-A7C5-D4B6D24111EBQ38903778-F37FEE53-F1CD-4AF0-823C-BADFD0222038Q39102984-40F6138C-BCE0-405A-9B7E-B7A5677AA5D7Q39128295-BC5F3F87-6124-4999-B959-786E7969052DQ39220800-60B58B11-2383-4B7C-A6B3-C00562C60870Q39307398-FCFF6F61-9275-4CF7-8442-623FFD7C4A21Q40070911-A606B291-B45E-41B7-9DD2-E94A9B119C75Q40378224-C932F35B-0948-4115-B825-16B35AF5C876Q41064092-C2700524-1379-4385-A199-1EEDC1033CB2Q41353159-3696F3C3-B6D5-44FC-815A-23BAE5913B81Q41615298-B2ECCE2F-A77F-45C8-9A4C-420E6BB14F93Q41730777-1E3332B5-7FD7-46D2-9DE2-433D47BBE77FQ41809569-8A3D1731-1E3F-49DC-9FC1-D2E18378FA28Q42371575-7C2C0374-9A7F-4358-A0CA-230D08B1D180Q43526669-D4699BE7-4811-4A3F-9949-FB18D7A0B5C3Q45848239-8EAFBFDF-4045-439F-963E-5B770283F5A1Q46407256-0082B9D5-2CC8-44BD-9122-3B4C30A93182
P2860
The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The attributable mortality and ...... ing in critically ill patients
@ast
The attributable mortality and ...... ing in critically ill patients
@en
The attributable mortality and ...... ing in critically ill patients
@nl
type
label
The attributable mortality and ...... ing in critically ill patients
@ast
The attributable mortality and ...... ing in critically ill patients
@en
The attributable mortality and ...... ing in critically ill patients
@nl
prefLabel
The attributable mortality and ...... ing in critically ill patients
@ast
The attributable mortality and ...... ing in critically ill patients
@en
The attributable mortality and ...... ing in critically ill patients
@nl
P2093
P2860
P3181
P356
P1433
P1476
The attributable mortality and ...... ing in critically ill patients
@en
P2093
D K Heyland
G H Guyatt
L E Griffith
S D Walter
P2860
P2888
P304
P3181
P356
10.1186/CC1071
P407
P577
2001-12-01T00:00:00Z